| GILD |
Gilead Sciences, Inc. |
137.03B |
5.36% |
|
|
|
|
|
109.95 |
-0.07% |
25.23% |
31.39% |
|---|
| UTHR |
United Therapeutics Corporation |
16.12B |
5.03% |
|
|
|
|
|
361.10 |
-1.70% |
35.09% |
97.66% |
|---|
| NTRA |
Natera, Inc. |
21.43B |
5.02% |
|
|
|
|
|
162.31 |
-3.50% |
53.42% |
52.65% |
|---|
| BIIB |
Biogen Inc. |
20.59B |
4.91% |
|
|
|
|
|
140.64 |
2.59% |
37.81% |
56.88% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
75.29B |
4.90% |
|
|
|
|
|
700.33 |
0.62% |
36.18% |
59.68% |
|---|
| INCY |
Incyte Corporation |
13.96B |
4.85% |
|
|
|
|
|
72.11 |
1.02% |
42.37% |
83.22% |
|---|
| ILMN |
Illumina, Inc. |
14.92B |
4.85% |
|
|
|
|
|
94.20 |
-3.09% |
46.36% |
37.89% |
|---|
| AMGN |
Amgen Inc. |
162.78B |
4.60% |
|
|
|
|
|
303.01 |
1.71% |
21.37% |
8.26% |
|---|
| NBIX |
Neurocrine Biosciences, Inc. |
12.03B |
3.08% |
|
|
|
|
|
120.69 |
3.94% |
34.71% |
22.61% |
|---|
| BCRX |
BioCryst Pharmaceuticals, Inc. |
1.91B |
2.98% |
|
|
|
|
|
9.21 |
-1.92% |
50.70% |
31.73% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
10.15B |
2.98% |
|
|
|
|
|
106.28 |
-1.96% |
49.27% |
16.33% |
|---|
| EXAS |
Exact Sciences Corporation |
9.12B |
2.93% |
|
|
|
|
|
49.26 |
-0.50% |
63.70% |
17.62% |
|---|
| QGEN |
Qiagen N.V. |
8.61B |
2.92% |
|
|
|
|
|
39.57 |
2.59% |
48.39% |
25.58% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
13.01B |
2.89% |
|
|
|
|
|
68.25 |
-0.70% |
33.04% |
28.31% |
|---|
| ACAD |
ACADIA Pharmaceuticals Inc. |
3.32B |
2.88% |
|
|
|
|
|
19.95 |
-1.68% |
52.38% |
52.95% |
|---|
| MNKD |
MannKind Corporation |
1.59B |
2.85% |
|
|
|
|
|
5.76 |
1.77% |
97.36% |
67.13% |
|---|
| CPRX |
Catalyst Pharmaceuticals, Inc. |
2.58B |
2.85% |
|
|
|
|
|
21.62 |
-1.95% |
42.34% |
61.47% |
|---|
| HALO |
Halozyme Therapeutics, Inc. |
7.11B |
2.83% |
|
|
|
|
|
57.75 |
0.54% |
37.56% |
45.45% |
|---|
| TECH |
Bio-Techne Corporation |
10.26B |
2.76% |
|
|
|
|
|
64.92 |
-0.87% |
40.49% |
40.03% |
|---|
| VCYT |
Veracyte, Inc. |
3.04B |
2.74% |
|
|
|
|
|
39.18 |
-4.56% |
62.23% |
50.66% |
|---|
| RPRX |
Royalty Pharma plc |
14.48B |
2.71% |
|
|
|
|
|
33.42 |
0.94% |
31.94% |
36.59% |
|---|
| BPMC |
Blueprint Medicines Corporation |
5.90B |
2.68% |
|
|
|
|
|
92.25 |
-2.23% |
66.68% |
15.72% |
|---|
| COLL |
Collegium Pharmaceutical, Inc. |
939.45M |
2.66% |
|
|
|
|
|
29.13 |
-2.08% |
55.89% |
53.37% |
|---|
| TGTX |
TG Therapeutics, Inc. |
4.81B |
2.64% |
|
|
|
|
|
30.88 |
-0.19% |
81.07% |
55.79% |
|---|
| XNCR |
Xencor, Inc. |
1.10B |
2.62% |
|
|
|
|
|
15.74 |
-0.32% |
81.40% |
45.37% |
|---|
| EXEL |
Exelixis, Inc. |
10.31B |
2.61% |
|
|
|
|
|
36.85 |
5.02% |
35.76% |
27.34% |
|---|
| AXSM |
Axsome Therapeutics, Inc. |
6.72B |
2.50% |
|
|
|
|
|
137.75 |
6.70% |
49.12% |
14.02% |
|---|
| CDNA |
CareDx, Inc |
1.20B |
2.46% |
|
|
|
|
|
22.29 |
-4.66% |
110.71% |
37.13% |
|---|
| PTGX |
Protagonist Therapeutics, Inc. |
2.31B |
2.41% |
|
|
|
|
|
38.75 |
0.68% |
68.70% |
84.70% |
|---|
| MYGN |
Myriad Genetics, Inc. |
1.29B |
2.40% |
|
|
|
|
|
14.18 |
-5.34% |
60.35% |
59.69% |
|---|
| AGPXX |
Invesco Government & Agency Portfolio |
|
0.08% |
|
|
|
|
|
|
|
|
|
|---|